# Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm

Study · id `cardio:ct-nct06835491` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06835491](<https://clinicaltrials.gov/study/NCT06835491>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06835491

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 674 participants.

## Technical summary

Registry record NCT06835491. Randomized; no masking; primary purpose prevention. Start 2025-11-06 (actual); primary completion 2027-01-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 674 participants (planned count; ClinicalTrials.gov record NCT06835491, source copy `cardio:ctgov-nct06835491-2025-12-23`, retrieved 2026-10-26)
- Started: 2025-11-06 (actual) (ClinicalTrials.gov record NCT06835491, source copy `cardio:ctgov-nct06835491-2025-12-23`, retrieved 2026-10-26)
- Primary completion: 2027-01-15 (anticipated) (ClinicalTrials.gov record NCT06835491, source copy `cardio:ctgov-nct06835491-2025-12-23`, retrieved 2026-10-26)
- Completion: 2027-03-15 (anticipated) (ClinicalTrials.gov record NCT06835491, source copy `cardio:ctgov-nct06835491-2025-12-23`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT06835491, source copy `cardio:ctgov-nct06835491-2025-12-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06835491-2025-12-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm
- Acronym: PARACA
- Condition: Ventricular Arrhythmias and Cardiac Arrest
- Intervention (Drug): Amiodarone
- Lead sponsor: Versailles Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry intervention name matches this record: Amiodarone (`cardio:amiodarone`)
- Registry lists this organization as the lead sponsor: Versailles Hospital (`cardio:org-versailles-hospital`)

## Provenance

Content hash: 9078c138b0600252bfae53a9eaddf0c04990f62c753fdadf693a98f52a7d7f42
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
